Merck joined the race to develop coronavirus treatments, and is buying Austrian vaccine maker Themis Bioscience and collaborating with research nonprofit IAVI to develop two separate vaccines
), were a month or two behind Moderna’s, but may get added to large efficacy trials this summer as they wrap up early-stage studies.Merck intends to shoulder the cost of scaling up production of the vaccines before either has been proven to work, although it has not yet determined where they will be manufactured commercially, he said.
Cantor Fitzgerald analyst Louise Chen said in a research note she expected Merck to be “an important player in the COVID-19 vaccines and treatments landscape” and called the approach to pursue multiple vaccine strategies “a good means to diversify risk.”Frazier said Merck had not signed any pacts with the U.S. government to deliver doses of either vaccine to Americans first, adding it was committed to making its vaccines accessible globally and affordably.
Frazier compared it to Gilead Sciences’ remdesivir, but it would be a pill, rather than an intravenous infusion. Efficacy trials will start later this year.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Merck Jumps Into The Race For A Coronavirus VaccineNew Jersey-based pharmaceutical Merck is undertaking 3 endeavors to fight Covid-19— including teaming up with nonprofit scientific research firm IAVI to develop a vaccine by lisettevoytko
続きを読む »
Merck in collaboration to develop a coronavirus vaccine, with clinical trials to start later this yearMost experts agree that it could take between 12 to 18 months for a safe-to-use vaccine to be rolled out to the market.
続きを読む »
Novavax begins human trials with potential Covid-19 vaccine in AustraliaNovavax will inject 131 volunteers in the first phase of the trial testing the safety of the vaccine and looking for signs of its effectiveness.
続きを読む »
India among 10 worst-hit COVID-19 nations as cases jump; air travel reopensIndia on Monday posted its biggest single-day jump in cases of COVID-19, overtaking Iran to become one of the 10 worst-hit nations, even as the government allowed domestic air travel to restart.
続きを読む »
Novavax Coronavirus Vaccine Begins Human TestingNovavax started the first human study of its experimental coronavirus vaccine, making it one of at least 10 shots now being tested in people globally for Covid-19
続きを読む »
Merck Jumps Into The Race For A Coronavirus VaccineNew Jersey-based pharmaceutical Merck is undertaking 3 endeavors to fight Covid-19— including teaming up with nonprofit scientific research firm IAVI to develop a vaccine by lisettevoytko
続きを読む »